The present invention relates to compositions and methods for the use of SENP1 as a marker for cancer diagnosis, specifically prostate cancer. Still further, it relates to the use of inhibitors of SENP1 to inhibit cell proliferation of a neoplasm or tumor cell and to treat a hyperproliferative disease.

 
Web www.patentalert.com

< Serpentine transmembrane antigens expressed in human cancers and uses thereof

> Cardiac muscle regeneration using mesenchymal stem cells

> Multivalent Clostridial toxin derivatives and methods of their use
~ 00543